Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients.
Takeshi EbiharaTsunehiro MatsubaraYuki TogamiHisatake MatsumotoJotaro TachinoHiroshi MatsuuraTakashi KojimaFuminori SugiharaShigeto SenoDaisuke OkuzakiHaruhiko HirataHiroshi OguraPublished in: Journal of clinical immunology (2022)
The use of these easily measured key proteins offered new insight into the pathogenesis of COVID-19 and could be useful in a potential clinical application.